Pulmonary arterial hypertension in scleroderma: care gaps in screening

One in six patients with systemic sclerosis will develop pulmonary arterial hypertension (PAH). Screening with echocardiography and possibly pulmonary function testing (to determine the diffusing capacity of c...

Source: Arthritis Research and Therapy - June 6, 2017 Category: Rheumatology Authors: Janet E. Pope Source Type: research